Category: Hepatitis
Hepatitis market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Hepatitis B Vaccines
The 2025-2030 World Outlook for Hepatitis B Vaccines This study covers the world outlook for hepatitis b vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Treatments
The 2025-2030 World Outlook for Hepatitis C Treatments This study covers the world outlook for hepatitis c treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Hepatitis Diagnostics
The 2025-2030 World Outlook for Hepatitis Diagnostics This study covers the world outlook for hepatitis diagnostics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Hepatitis Therapeutics
The 2025-2030 World Outlook for Hepatitis Therapeutics This study covers the world outlook for hepatitis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests
The 2025-2030 World Outlook for Viral Hepatitis and Retrovirus Diagnostic Tests This study covers the world outlook for viral hepatitis and retrovirus diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Diagnostic Tests
The 2025-2030 World Outlook for Hepatitis B Diagnostic Tests This study covers the world outlook for hepatitis b diagnostic tests across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Therapies
The 2025-2030 World Outlook for Hepatitis C Therapies This study covers the world outlook for hepatitis c therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Hepatitis Drugs
The 2025-2030 World Outlook for Hepatitis Drugs This study covers the world outlook for hepatitis drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2025-2030 World Outlook for Viral Infection Treatments
The 2025-2030 World Outlook for Viral Infection Treatments This study covers the world outlook for viral infection treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Therapeutics
The 2025-2030 World Outlook for Hepatitis C Therapeutics This study covers the world outlook for hepatitis c therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Hepatitis Test Solution-Diagnosis
The 2025-2030 World Outlook for Hepatitis Test Solution-Diagnosis This study covers the world outlook for hepatitis test solution-diagnosis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Hepatitis B Therapeutics
The 2025-2030 World Outlook for Hepatitis B Therapeutics This study covers the world outlook for hepatitis b therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Anti-Hepatitis Drugs and Vaccines
The 2025-2030 World Outlook for Anti-Hepatitis Drugs and Vaccines This study covers the world outlook for anti-hepatitis drugs and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Hepatitis C Drugs
The 2025-2030 World Outlook for Hepatitis C Drugs This study covers the world outlook for hepatitis c drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2025-2030 World Outlook for Mono Hepatitis B Vaccines
The 2025-2030 World Outlook for Mono Hepatitis B Vaccines This study covers the world outlook for mono hepatitis B vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
Research Assistance
